InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

REPLIGEN CORP

RGEN Clue Score51
United States Fiscal year ends December CIK 0000730272 Results filed 27 Oct 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

117
Insider
Date
Role
Action
Shares
Price
Amount
Olivier Loeillot
5 Oct 2026
Chief Executive Officer
Sold after exercise
4,202
$190.00
$798.38K
Olivier Loeillot
5 Oct 2026
Chief Executive Officer
Sold after exercise
1,333
$178.75
$238.27K
Olivier Loeillot
24 Sep 2026
Chief Executive Officer
Sold after exercise
4,542
$190.00
$862.98K
Olivier Loeillot
24 Sep 2026
Chief Executive Officer
Sold after exercise
8,404
$190.00
$1.60M
Olivier Loeillot
21 Sep 2026
Chief Executive Officer
Sold after exercise
5,426
$180.00
$976.68K
Olivier Loeillot
20 Aug 2026
Chief Executive Officer
Sold after exercise
5,426
$180.00
$976.68K
Anthony Hunt
13 Nov 2025
Director
Sold after exercise
1,956
$157.11
$307.31K
Anthony Hunt
13 Nov 2025
Director
Sold after exercise
5,737
$156.22
$896.23K
Anthony Hunt
13 Nov 2025
Director
Sold after exercise
3,000
$155.45
$466.35K
Anthony Hunt
13 Nov 2025
Director
Sold after exercise
2,500
$154.32
$385.80K
Anthony Hunt
13 Nov 2025
Director
Sold after exercise
2,923
$153.14
$447.63K
Anthony Hunt
13 Nov 2025
Director
Sold after exercise
2,100
$152.17
$319.56K
Anthony Hunt
13 Nov 2025
Director
Sold after exercise
1,784
$151.01
$269.40K
Anthony Hunt
12 Nov 2025
Director
Sold after exercise
464
$158.51
$73.55K
Anthony Hunt
12 Nov 2025
Director
Sold after exercise
11,096
$158.01
$1.75M
Anthony Hunt
12 Nov 2025
Director
Sold after exercise
4,959
$156.65
$776.83K
Anthony Hunt
12 Nov 2025
Director
Sold after exercise
4,740
$155.85
$738.73K
Anthony Hunt
12 Nov 2025
Director
Sold after exercise
3,741
$154.92
$579.56K
Anthony Hunt
10 Sep 2025
Director
Sold after exercise
2,179
$122.23
$266.34K
Anthony Hunt
10 Sep 2025
Director
Sold after exercise
7,584
$121.42
$920.85K
Anthony Hunt
10 Sep 2025
Director
Sold after exercise
14,882
$120.19
$1.79M
Anthony Hunt
10 Sep 2025
Director
Sold after exercise
3,262
$119.64
$390.27K
Anthony Hunt
10 Sep 2025
Director
Sold after exercise
1,108
$118.32
$131.10K
Anthony Hunt
10 Sep 2025
Director
Sold after exercise
96
$116.34
$11.17K
Anthony Hunt
17 Mar 2025
Director
Sold after exercise
2,283
$153.70
$350.90K
Anthony Hunt
17 Mar 2025
Director
Sold after exercise
15,619
$152.82
$2.39M
Anthony Hunt
17 Mar 2025
Director
Sold after exercise
6,176
$151.96
$938.50K
Anthony Hunt
17 Mar 2025
Director
Sold after exercise
2,518
$151.09
$380.44K
Anthony Hunt
17 Mar 2025
Director
Sold after exercise
100
$150.38
$15.04K
Anthony Hunt
17 Mar 2025
Director
Sold after exercise
60
$148.05
$8.88K
Anthony Hunt
21 Nov 2024
Director
Sold after exercise
24,246
$139.67
$3.39M
Anthony Hunt
10 Sep 2024
Director
Sold after exercise
604
$146.67
$88.59K
Anthony Hunt
10 Sep 2024
Director
Sold after exercise
10,723
$145.95
$1.57M
Anthony Hunt
10 Sep 2024
Director
Sold after exercise
9,369
$144.88
$1.36M
Anthony Hunt
10 Sep 2024
Director
Sold after exercise
1,495
$143.77
$214.94K
Ralf Kuriyel
2 Aug 2024
Senior VP, R&D
Sold after exercise
175
$158.85
$27.80K
Ralf Kuriyel
2 Aug 2024
Senior VP, R&D
Sold after exercise
6,973
$159.36
$1.11M
Ralf Kuriyel
11 Mar 2024
Senior VP, R&D
Sold after exercise
3,517
$193.73
$681.35K
Anthony Hunt
8 Mar 2024
Chief Executive Officer
Sold after exercise
156
$202.55
$31.60K
Anthony Hunt
8 Mar 2024
Chief Executive Officer
Sold after exercise
806
$201.75
$162.61K
Anthony Hunt
8 Mar 2024
Chief Executive Officer
Sold after exercise
1,305
$200.56
$261.73K
Anthony Hunt
8 Mar 2024
Chief Executive Officer
Sold after exercise
1,822
$199.53
$363.54K
Anthony Hunt
8 Mar 2024
Chief Executive Officer
Sold after exercise
1,347
$198.55
$267.45K
Anthony Hunt
8 Mar 2024
Chief Executive Officer
Sold after exercise
1,666
$197.39
$328.85K
Anthony Hunt
8 Mar 2024
Chief Executive Officer
Sold after exercise
6,228
$196.32
$1.22M
Anthony Hunt
8 Mar 2024
Chief Executive Officer
Sold after exercise
3,377
$195.49
$660.17K
Karen A Dawes
27 Feb 2024
Director
Sold after exercise
1,000
$193.35
$193.35K
James Bylund
23 Feb 2024
Chief Operating Officer
Sold after exercise
4,373
$198.08
$866.20K
Karen A Dawes
29 Aug 2023
Director
Sold after exercise
850
$171.38
$145.67K
Anthony Hunt
11 Nov 2022
Chief Executive Officer
Sold after exercise
25,000
$200.00
$5.00M
Anthony Hunt
8 Sep 2022
Chief Executive Officer
Sold after exercise
245
$227.01
$55.62K
Anthony Hunt
8 Sep 2022
Chief Executive Officer
Sold after exercise
4,873
$226.34
$1.10M
Anthony Hunt
8 Sep 2022
Chief Executive Officer
Sold after exercise
10,490
$225.22
$2.36M
Anthony Hunt
8 Sep 2022
Chief Executive Officer
Sold after exercise
6,626
$224.47
$1.49M
Anthony Hunt
8 Sep 2022
Chief Executive Officer
Sold after exercise
1,389
$223.26
$310.11K
Anthony Hunt
8 Sep 2022
Chief Executive Officer
Sold after exercise
720
$222.24
$160.01K
Anthony Hunt
8 Sep 2022
Chief Executive Officer
Sold after exercise
1,235
$221.46
$273.50K
Anthony Hunt
8 Sep 2022
Chief Executive Officer
Sold after exercise
824
$220.08
$181.35K
Jon Snodgres
16 Aug 2022
Chief Financial Officer
Sold after exercise
2,400
$253.16
$607.58K
Jon Snodgres
16 Aug 2022
Chief Financial Officer
Sold after exercise
4,298
$252.70
$1.09M
Ralf Kuriyel
11 Aug 2022
Senior VP, R&D
Sold after exercise
4,040
$254.14
$1.03M
Ralf Kuriyel
11 Aug 2022
Senior VP, R&D
Sold after exercise
800
$255.20
$204.16K
James Bylund
3 Aug 2022
Chief Operating Officer
Sold after exercise
2,000
$240.40
$480.80K
Anthony Hunt
21 Jul 2022
Chief Executive Officer
Sold after exercise
24,802
$200.00
$4.96M
Thomas F Ryan Jr
1 Mar 2022
Director
Sold after exercise
1,000
$197.58
$197.58K
Thomas F Ryan Jr
1 Mar 2022
Director
Sold after exercise
1,000
$198.48
$198.48K
Anthony Hunt
18 Nov 2021
Chief Executive Officer
Sold after exercise
596
$281.40
$167.71K
Anthony Hunt
18 Nov 2021
Chief Executive Officer
Sold after exercise
970
$279.08
$270.71K
Anthony Hunt
18 Nov 2021
Chief Executive Officer
Sold after exercise
6,024
$278.08
$1.68M
Anthony Hunt
18 Nov 2021
Chief Executive Officer
Sold after exercise
1,732
$277.01
$479.78K
Anthony Hunt
18 Nov 2021
Chief Executive Officer
Sold after exercise
4,017
$276.20
$1.11M
Anthony Hunt
18 Nov 2021
Chief Executive Officer
Sold after exercise
1,955
$274.83
$537.29K
Anthony Hunt
18 Nov 2021
Chief Executive Officer
Sold after exercise
2,061
$273.91
$564.53K
Karen A Dawes
10 Nov 2021
Director
Sold after exercise
14
$271.28
$3.80K
Karen A Dawes
10 Nov 2021
Director
Sold after exercise
255
$269.94
$68.83K
Karen A Dawes
10 Nov 2021
Director
Sold after exercise
349
$267.75
$93.44K
Karen A Dawes
10 Nov 2021
Director
Sold after exercise
486
$266.72
$129.63K
Karen A Dawes
10 Nov 2021
Director
Sold after exercise
488
$265.27
$129.45K
Karen A Dawes
10 Nov 2021
Director
Sold after exercise
336
$264.21
$88.77K
Karen A Dawes
10 Nov 2021
Director
Sold after exercise
1,119
$263.23
$294.55K
Karen A Dawes
10 Nov 2021
Director
Sold after exercise
1,038
$262.28
$272.25K
Karen A Dawes
10 Nov 2021
Director
Sold after exercise
236
$261.10
$61.62K
Karen A Dawes
10 Nov 2021
Director
Sold after exercise
462
$259.75
$120.00K
Thomas F Ryan Jr
2 Nov 2021
Director
Sold after exercise
1,285
$302.00
$388.07K
Nicolas Barthelemy
29 Oct 2021
Director
Sold after exercise
360
$288.19
$103.75K
Nicolas Barthelemy
29 Oct 2021
Director
Sold after exercise
1,285
$288.20
$370.34K
Anthony Hunt
9 Sep 2021
Chief Executive Officer
Sold after exercise
8
$296.58
$2.37K
Anthony Hunt
9 Sep 2021
Chief Executive Officer
Sold after exercise
1,631
$296.09
$482.92K
Anthony Hunt
9 Sep 2021
Chief Executive Officer
Sold after exercise
14,825
$294.90
$4.37M
Anthony Hunt
9 Sep 2021
Chief Executive Officer
Sold after exercise
8,536
$294.22
$2.51M
Karen A Dawes
1 Sep 2021
Director
Sold after exercise
851
$285.44
$242.91K
Karen A Dawes
1 Sep 2021
Director
Sold after exercise
1,107
$284.64
$315.10K
Karen A Dawes
1 Sep 2021
Director
Sold after exercise
661
$283.56
$187.43K
Karen A Dawes
1 Sep 2021
Director
Sold after exercise
405
$282.53
$114.42K
Karen A Dawes
1 Sep 2021
Director
Sold after exercise
196
$281.68
$55.21K
Karen A Dawes
1 Sep 2021
Director
Sold after exercise
239
$280.27
$66.98K
Karen A Dawes
13 Jul 2021
Director
Sold after exercise
1,520
$202.23
$307.39K
Ralf Kuriyel
10 Jun 2021
Senior VP, R&D
Sold after exercise
6,802
$189.19
$1.29M
Karen A Dawes
11 May 2021
Director
Sold after exercise
285
$176.85
$50.40K
Ralf Kuriyel
10 Mar 2021
Senior VP, R&D
Sold after exercise
1,004
$192.13
$192.90K
Ralf Kuriyel
10 Mar 2021
Senior VP, R&D
Sold after exercise
642
$191.33
$122.83K
Ralf Kuriyel
10 Mar 2021
Senior VP, R&D
Sold after exercise
6,354
$190.08
$1.21M
Thomas F Ryan Jr
3 Mar 2021
Director
Sold after exercise
1,000
$205.00
$205.00K
Anthony Hunt
19 Nov 2020
Chief Executive Officer
Sold after exercise
1,430
$187.60
$268.27K
Anthony Hunt
19 Nov 2020
Chief Executive Officer
Sold after exercise
6,300
$186.50
$1.17M
Anthony Hunt
19 Nov 2020
Chief Executive Officer
Sold after exercise
6,823
$185.67
$1.27M
Anthony Hunt
19 Nov 2020
Chief Executive Officer
Sold after exercise
5,447
$184.69
$1.01M
Thomas F Ryan Jr
11 Nov 2020
Director
Sold after exercise
934
$187.73
$175.34K
Jon Snodgres
10 Nov 2020
Chief Financial Officer
Sold after exercise
3,086
$193.00
$595.60K
Jon Snodgres
9 Nov 2020
Chief Financial Officer
Sold after exercise
705
$194.69
$137.26K
Anthony Hunt
10 Sep 2020
Chief Executive Officer
Sold after exercise
2,397
$149.30
$357.87K
Anthony Hunt
10 Sep 2020
Chief Executive Officer
Sold after exercise
26,966
$148.56
$4.01M
Anthony Hunt
10 Sep 2020
Chief Executive Officer
Sold after exercise
11,132
$147.68
$1.64M
Anthony Hunt
10 Sep 2020
Chief Executive Officer
Sold after exercise
4,856
$146.85
$713.10K
Ralf Kuriyel
6 Aug 2020
Senior VP, R&D
Sold after exercise
5,000
$153.79
$768.95K
Thomas F Ryan Jr
31 Jul 2020
Director
Sold after exercise
986
$151.77
$149.65K
Thomas F Ryan Jr
31 Jul 2020
Director
Sold after exercise
2,109
$151.96
$320.48K
Showing 250 of 369 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 354
Amendments (4/A) skipped 15
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 16
Sales straight out of an exercise 160
Sales at will 170
Transactions with no price 0
Shares from compensation/vesting 3,091,951
Sales filed before the plan box existed 166
History held since 6 Dec 2006